Login / Signup

Clinical outcomes of continuous flow left ventricular assist device therapy as bridge to transplant strategy in muscular dystrophy: a single-center study.

Takayuki GyotenEisuke AmiyaOsamu KinoshitaMasaki TsujiMitsutoshi KimuraMasaru HatanoMinoru Ono
Published in: General thoracic and cardiovascular surgery (2022)
In selected MD patients with end-stage HF, cf-LVAD therapy is a viable therapeutic option as bridge to heart transplant.
Keyphrases
  • left ventricular assist device
  • muscular dystrophy
  • cystic fibrosis
  • heart failure
  • atrial fibrillation
  • molecular dynamics